Cost-of-illness analysis of type 2 diabetes mellitus in Iran.

<h4>Introduction</h4>Diabetes is a worldwide high prevalence chronic progressive disease that poses a significant challenge to healthcare systems. The aim of this study is to provide a detailed economic burden of diagnosed type 2 diabetes mellitus (T2DM) and its complications in Iran in...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mehdi Javanbakht, Hamid R Baradaran, Atefeh Mashayekhi, Ali Akbar Haghdoost, Mohammad E Khamseh, Erfan Kharazmi, Aboozar Sadeghi
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2011
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/444232e51f454d8fb96ff89d57244fec
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:444232e51f454d8fb96ff89d57244fec
record_format	dspace
spelling	oai:doaj.org-article:444232e51f454d8fb96ff89d57244fec2021-11-18T07:35:22ZCost-of-illness analysis of type 2 diabetes mellitus in Iran.1932-620310.1371/journal.pone.0026864https://doaj.org/article/444232e51f454d8fb96ff89d57244fec2011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22066013/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Introduction</h4>Diabetes is a worldwide high prevalence chronic progressive disease that poses a significant challenge to healthcare systems. The aim of this study is to provide a detailed economic burden of diagnosed type 2 diabetes mellitus (T2DM) and its complications in Iran in 2009 year.<h4>Methods</h4>This is a prevalence-based cost-of-illness study focusing on quantifying direct health care costs by bottom-up approach. Data on inpatient hospital services, outpatient clinic visits, physician services, drugs, laboratory test, education and non-medical cost were collected from two national registries. The human capital approach was used to calculate indirect costs separately in male and female and also among different age groups.<h4>Results</h4>The total national cost of diagnosed T2DM in 2009 is estimated at 3.78 billion USA dollars (USD) including 2.04±0.28 billion direct (medical and non-medical) costs and indirect costs of 1.73 million. Average direct and indirect cost per capita was 842.6±102 and 864.8 USD respectively. Complications (48.9%) and drugs (23.8%) were main components of direct cost. The largest components of medical expenditures attributed to diabetes's complications are cardiovascular disease (42.3% of total Complications cost), nephropathy (23%) and ophthalmic complications (14%). Indirect costs include temporarily disability (335.7 million), permanent disability (452.4 million) and reduced productivity due to premature mortality (950.3 million).<h4>Conclusions</h4>T2DM is a costly disease in the Iran healthcare system and consume more than 8.69% of total health expenditure. In addition to these quantified costs, T2DM imposes high intangible costs on society in terms of reduced quality of life. Identification of effective new strategies for the control of diabetes and its complications is a public health priority.Mehdi JavanbakhtHamid R BaradaranAtefeh MashayekhiAli Akbar HaghdoostMohammad E KhamsehErfan KharazmiAboozar SadeghiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 10, p e26864 (2011)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Mehdi Javanbakht Hamid R Baradaran Atefeh Mashayekhi Ali Akbar Haghdoost Mohammad E Khamseh Erfan Kharazmi Aboozar Sadeghi Cost-of-illness analysis of type 2 diabetes mellitus in Iran.
description	<h4>Introduction</h4>Diabetes is a worldwide high prevalence chronic progressive disease that poses a significant challenge to healthcare systems. The aim of this study is to provide a detailed economic burden of diagnosed type 2 diabetes mellitus (T2DM) and its complications in Iran in 2009 year.<h4>Methods</h4>This is a prevalence-based cost-of-illness study focusing on quantifying direct health care costs by bottom-up approach. Data on inpatient hospital services, outpatient clinic visits, physician services, drugs, laboratory test, education and non-medical cost were collected from two national registries. The human capital approach was used to calculate indirect costs separately in male and female and also among different age groups.<h4>Results</h4>The total national cost of diagnosed T2DM in 2009 is estimated at 3.78 billion USA dollars (USD) including 2.04±0.28 billion direct (medical and non-medical) costs and indirect costs of 1.73 million. Average direct and indirect cost per capita was 842.6±102 and 864.8 USD respectively. Complications (48.9%) and drugs (23.8%) were main components of direct cost. The largest components of medical expenditures attributed to diabetes's complications are cardiovascular disease (42.3% of total Complications cost), nephropathy (23%) and ophthalmic complications (14%). Indirect costs include temporarily disability (335.7 million), permanent disability (452.4 million) and reduced productivity due to premature mortality (950.3 million).<h4>Conclusions</h4>T2DM is a costly disease in the Iran healthcare system and consume more than 8.69% of total health expenditure. In addition to these quantified costs, T2DM imposes high intangible costs on society in terms of reduced quality of life. Identification of effective new strategies for the control of diabetes and its complications is a public health priority.
format	article
author	Mehdi Javanbakht Hamid R Baradaran Atefeh Mashayekhi Ali Akbar Haghdoost Mohammad E Khamseh Erfan Kharazmi Aboozar Sadeghi
author_facet	Mehdi Javanbakht Hamid R Baradaran Atefeh Mashayekhi Ali Akbar Haghdoost Mohammad E Khamseh Erfan Kharazmi Aboozar Sadeghi
author_sort	Mehdi Javanbakht
title	Cost-of-illness analysis of type 2 diabetes mellitus in Iran.
title_short	Cost-of-illness analysis of type 2 diabetes mellitus in Iran.
title_full	Cost-of-illness analysis of type 2 diabetes mellitus in Iran.
title_fullStr	Cost-of-illness analysis of type 2 diabetes mellitus in Iran.
title_full_unstemmed	Cost-of-illness analysis of type 2 diabetes mellitus in Iran.
title_sort	cost-of-illness analysis of type 2 diabetes mellitus in iran.
publisher	Public Library of Science (PLoS)
publishDate	2011
url	https://doaj.org/article/444232e51f454d8fb96ff89d57244fec
work_keys_str_mv	AT mehdijavanbakht costofillnessanalysisoftype2diabetesmellitusiniran AT hamidrbaradaran costofillnessanalysisoftype2diabetesmellitusiniran AT atefehmashayekhi costofillnessanalysisoftype2diabetesmellitusiniran AT aliakbarhaghdoost costofillnessanalysisoftype2diabetesmellitusiniran AT mohammadekhamseh costofillnessanalysisoftype2diabetesmellitusiniran AT erfankharazmi costofillnessanalysisoftype2diabetesmellitusiniran AT aboozarsadeghi costofillnessanalysisoftype2diabetesmellitusiniran
_version_	1718423218807635968

Cost-of-illness analysis of type 2 diabetes mellitus in Iran.

Ejemplares similares